Global Manufacturing, Supply & Distribution

Expanding our reach is just one way we can help close the health equity gap, but we can’t do it alone. ‘An Accord for a Healthier World’ is our vision for stronger health systems globally, in partnership with global health leaders, organizations, country governments, industry leaders, and peers.

We’ve ramped up manufacturing capabilities for gene therapy by investing in a Stage 2 facility in Sanford, NC.

Scaling mRNA manufacturing platforms for more uses allows vaccines to be adapted as needed and address new virus strains as quickly as possible.

We’re leading the way in cold chain technology to safely deliver medicines that require ultra-cold storage, including gene therapy, mRNA vaccines, and more.

This technology was recognized as the supply chain breakthrough of 2022 by the Garter Power of the Procession Supply Chain Awards.

Thermal sensors proactively track location and temperature of each shipment 24/7, and artificial intelligence analyzes data that minimizes risk, improves responsiveness, increases visibility, and future-proofs operations at every point.

We’re tackling present and future sustainability challenges by implementing more efficient manufacturing technologies for minimal adverse impact on the environment, aiming for a Net-Zero Standard across the value chain by 2040.

We’re investing in local communities and expanding our key manufacturing areas in the U.S. to strengthen our broad, global network.